Biotech · Private company
Remedy Pharmaceuticals, Inc.
Track this companyFree. Adds Remedy Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- BIIB093Phase 3 · Brain EdemaClinicalTrials.gov · fetched Nov 12, 2026
- BIIB093Phase 2 · Brain ContusionClinicalTrials.gov · fetched Nov 12, 2026
- GlyburidePhase 2 · Traumatic Brain InjuryClinicalTrials.gov · fetched Nov 12, 2026
- Glyburide for InjectionPhase 2 · Ischemic StrokeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- A Study to Evaluate the Efficacy and Safety of BIIB093 in Participants With Brain ContusionPHASE2 · TERMINATED · started Oct 6, 2019ClinicalTrials.gov NCT03954041 · fetched Nov 12, 2026
- Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric InfarctionPHASE3 · TERMINATED · started Aug 29, 2018ClinicalTrials.gov NCT02864953 · fetched Nov 12, 2026
- Glyburide Advantage in Malignant Edema and Stroke - Remedy PharmaceuticalsPHASE2 · COMPLETED · started Jun 13, 2013ClinicalTrials.gov NCT01794182 · fetched Nov 12, 2026
- Glyburide (RP-1127) for Traumatic Brain Injury (TBI)PHASE2 · COMPLETED · started Dec 17, 2011ClinicalTrials.gov NCT01454154 · fetched Nov 12, 2026
- Glyburide Advantage in Malignant Edema and Stroke PilotPHASE1_PHASE2 · COMPLETED · started May 26, 2011ClinicalTrials.gov NCT01268683 · fetched Nov 12, 2026